R&D Team

Researchers at Redoxis all have long experience and knowledge of autoimmune diseases, expertise in animal models, medicinal chemistry and preclinical drug development. The combination of different competences of Redoxis R&D team, the flexibility and efficient work models makes Redoxis an excellent environment for innovation and research development.

Peter Olofsson, MBA, PhD CEO Mobile: +46 709 164608 peter.olofsson@redoxis.com			Malin Hultqvist, PhD CSO Tel: +46 707 259565 malin.hultqvist@redoxis.com
Fredrik Wallner, PhD Project leader, Medicinal Chemistry Tel: +46 706 362472 fredrik.wallner@redoxis.com			Therese Lindvall, PhD Project leader, Target validation Tel: +46 706 053960 therese.lindvall@redoxis.com
Nina Woodworth, M.Sc. Project leader, CRO Tel: +46 760 567842 nina.woodworth@redoxis.com			Caroline Johnsson, M.Sc. Scientist Biology, Assay Development Tel: +46 735 352106 caroline.johnsson@redoxis.com